Reversing Caremark recoupments. Reinstating terminated pharmacies.
Request a Free Case ReviewCVS Caremark runs one of the most aggressive PBM audit programs in the United States. A single flagged claim can trigger six- and seven-figure recoupments, termination for cause, and downstream loss of Aetna commercial, SilverScript Medicare Part D, and CVS Pharmacy network access. We defend pharmacies nationwide before the audit closes. Every day of delay changes your settlement posture.
.png)
Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
With upmost professional respect, I will be forever grateful to have such caring individuals as Attorney Anthony Mahajan and Attorney Diana Yastrovskaya who come into my life, even though I am a business owner but I always felt I was treated as a friend and was made reaching out to them with ease.
I had a great experience working with Health Law Alliance. From the very beginning, their team was incredibly helpful, responsive, and professional. They answered all of my questions quickly and kept me informed throughout the entire process.
Anthony and his staff have gone above and beyond. His proactive communication and ability to handle complex legal scenarios effectively have been a significant asset. Highly recommended attorney.
Top-notch attorneys with an unparalleled scope of experience and breadth of knowledge. You will want them in your corner.
Had nothing but great experience from them. Knowledgeable and professional in all aspects. They have a vast knowledge in health care cases, great to be on your side against insurances.
Trustworthy and experienced.
By the time the Caremark notice arrives, the downstream exposure is already stacked. Here is what your pharmacy is actually defending against.
Caremark audit findings routinely demand recoupments of $250K to $4M+ per matter, with the audit team aggressively extrapolating a sampled-claim error rate across 12 to 24 months of total dispensing. Defense requires challenging both the sampled findings and the extrapolation methodology.
A Caremark termination for cause designation flows downstream across the entire CVS Health enterprise: Aetna commercial, SilverScript Medicare Part D, and the CVS Pharmacy network operated by the parent. Credentialing impact across multiple payors typically lands within 30 days of the termination notice.
CVS Caremark audit findings on controlled substances, compounding, and high-cost specialty claims are routinely referred to DEA, DOJ, HHS-OIG, and state boards of pharmacy. A PBM finding can become a civil investigative demand, a state board complaint, or a federal healthcare fraud investigation within weeks.
Four factors make CVS Caremark recoupments uniquely dangerous, and uniquely defensible if you know where CVS Caremark is actually vulnerable.
A PBM audit runs on the deadlines in your network agreement. What you produce, and when, becomes the record the PBM uses to set findings, chargebacks, and any network action.
Our bench includes a former Assistant U.S. Attorney (DOJ Director's Award nominee) and senior PBM operational counsel. We have run more than 2,000 audits across the major PBMs, including Caremark. This is how we dismantle a Caremark audit.
Within 24 hours: parse every deadline in the Caremark audit notice, place a litigation hold on the claims at issue, and preserve adjudication logs and signature records before Caremark's evidentiary window narrows.
Claim-by-claim reconstruction at the NDC level: prescriber PA rationale, formulary tier at time of fill, step therapy requirements documented or overridden, plan criteria at time of fill, DAW code support, signature log validation, and controlled substance recordkeeping. Every flagged claim gets its own defense memo tied back to the Caremark provider manual citation.
We draft and file the written Caremark appeal, quantify the extrapolation errors, and negotiate directly with the Caremark audit team and provider relations on behalf of the pharmacy.
If Caremark refuses a reasonable resolution, we file in federal court and pair the suit with regulatory defense at DEA, HHS-OIG, and the state board so a PBM dispute does not escalate into a license action or a criminal referral.
Health Law Alliance handles the response and any parallel appeal, licensing matter or referral as one coordinated matter, so the strategy does not change hands as the matter moves between forums.
The bench includes a former Assistant U.S. Attorney nominated for the DOJ Director's Award, senior healthcare-company counsel, and attorney-providers with experience across healthcare audits and investigations.
Agency and company marks identify former professional experience of individual HLA team members. They do not imply affiliation, endorsement, or a client relationship.
If any of these describe your 2024 to 2026 Caremark-billed dispensing activity, you are already in the Caremark audit pool whether or not the notice has arrived.
Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.
Network Reinstated
A compounding pharmacy received a Caremark termination for cause tied to compounded GLP-1 dispensing during the FDA shortage period. HLA's appeal brief documented compliance with the 503A pathway in effect on the dispense dates, addressed the OON appeal procedural record, and obtained full reinstatement across Caremark, SilverScript, and Aetna without a recoupment.
Recoupment Reversed
A multi-location independent pharmacy faced a Caremark specialty audit citing DAW code mismatches and signature log gaps across 18 months of dispenses. HLA reconstructed the underlying claims, challenged the extrapolation methodology, and negotiated a final settlement substantially below the original recoupment demand.
State Board Closed
A Caremark on-site audit produced a state board of pharmacy referral alleging recordkeeping and dispensing violations. HLA's regulatory response addressed each cited deficiency and documented compliance with the state pharmacy practice act on the dispense dates; the board closed the matter with no discipline.
Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific audit.
Eight questions that come up on almost every first call.
Before you write a single page of your Caremark response, have a privileged conversation with attorneys who have overseen 2,000+ audits across the major PBMs, including reversed Caremark terminations and reduced Caremark recoupments. Free, confidential, no retainer.